Evidence map›Paper›PMID 35319274›Full record

Trial reportCannabis and cannabinoid research2023

Delta-9-Tetrahydrocannabinol, Cannabidiol, and Acute Psychotomimetic States: A Balancing Act of the Principal Phyto-Cannabinoids on Human Brain and Behavior.

Suhas Ganesh, Jose Cortes-Briones, Ashley M Schnakenberg Martin, Patrick D Skosnik, Deepak C D'Souza, Mohini Ranganathan

Open access · greenAbstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Cannabis and cannabinoid research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Suhas GaneshDepartment of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA.ORCID 0000-0003-1833-1986
Jose Cortes-BrionesDepartment of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA.
Ashley M Schnakenberg MartinDepartment of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA.
Patrick D SkosnikDepartment of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA.
Deepak C D'SouzaDepartment of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA.
Mohini RanganathanDepartment of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA.
Yale University · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Cannabidiol Modulation of ???-9-THC???s Psychotomimetic Effects in Healthy HumansR21DA030696 · NIDA · YALE UNIVERSITY · PI D'SOUZA, DEEPAK CYRIL, RANGANATHAN, MOHINI · 2011 to 2012
$360k
NCATS NIH HHS UL1 TR001863NIDA NIH HHS R21 DA030696
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CannabidiolCannabinoidsCannabisHallucinogensBrainDronabinolFemaleHumansCannabidiolCannabinoidsDronabinolHallucinogensCBDdelta-9-tetrahydrocannabinolelectrophysiologyLempel-Ziv complexityneural noisepsychosis

Identifiers

PMID35319274
PMCPMC10589482
OpenAlexW4220948127

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.